These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35349827)

  • 61. Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses.
    Fraser DD; Cepinskas G; Slessarev M; Martin CM; Daley M; Patel MA; Miller MR; Patterson EK; O'Gorman DB; Gill SE; Higgins I; John JPP; Melo C; Nini L; Wang X; Zeidler J; Cruz-Aguado JA
    Pathophysiology; 2021 May; 28(2):212-223. PubMed ID: 35366258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Comparison of Monocyte Human Leukocyte Antigen-D-Related (mHLA-DR) Expression Levels Between Corona Virus Disease 2019 (COVID-19) Patients and Healthy Subjects.
    Nabilah MH; Wardhani P; Aryati A; Hernaningsih Y; Semedi BP
    Acta Med Indones; 2023 Jan; 55(1):52-60. PubMed ID: 36999265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
    Taeschler P; Adamo S; Deng Y; Cervia C; Zurbuchen Y; Chevrier S; Raeber ME; Hasler S; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Bodenmiller B; Boyman O; Nilsson J
    Allergy; 2022 Aug; 77(8):2468-2481. PubMed ID: 35567391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T cell response to SARS-CoV-2 infection in humans: A systematic review.
    Shrotri M; van Schalkwyk MCI; Post N; Eddy D; Huntley C; Leeman D; Rigby S; Williams SV; Bermingham WH; Kellam P; Maher J; Shields AM; Amirthalingam G; Peacock SJ; Ismail SA
    PLoS One; 2021; 16(1):e0245532. PubMed ID: 33493185
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study.
    Peronnet E; Blein S; Venet F; Cerrato E; Fleurie A; Llitjos JF; Kreitmann L; Terraz G; Conti F; Gossez M; Rimmelé T; Textoris J; Lukaszewicz AC; Brengel-Pesce K; Monneret G;
    Crit Care Med; 2023 Jun; 51(6):808-816. PubMed ID: 36917594
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.
    Berentschot JC; Drexhage HA; Aynekulu Mersha DG; Wijkhuijs AJM; GeurtsvanKessel CH; Koopmans MPG; Voermans JJC; Hendriks RW; Nagtzaam NMA; de Bie M; Heijenbrok-Kal MH; Bek LM; Ribbers GM; van den Berg-Emons RJG; Aerts JGJV; Dik WA; Hellemons ME
    Front Immunol; 2023; 14():1254899. PubMed ID: 37881427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.
    Files JK; Boppana S; Perez MD; Sarkar S; Lowman KE; Qin K; Sterrett S; Carlin E; Bansal A; Sabbaj S; Long DM; Kutsch O; Kobie J; Goepfert PA; Erdmann N
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33119547
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients.
    Monneret G; Voirin N; Richard JC; Cour M; Rimmelé T; Garnier L; Yonis H; Coudereau R; Gossez M; Malcus C; Wallet F; Delignette MC; Dailler F; Buisson M; Argaud L; Lukaszewicz AC; Venet F;
    Ann Intensive Care; 2024 May; 14(1):76. PubMed ID: 38762684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients.
    Borges Russo MK; Kowalewski LS; da Natividade GR; de Lemos Muller CH; Schroeder HT; Bock PM; Ayres LR; Cardoso BU; Zanotto C; Schein JT; Rech TH; Crispim D; Canani LH; Friedman R; Leitão CB; Gerchman F; Krause M
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?
    Rubio-Casillas A; Redwan EM; Uversky VN
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759738
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model.
    Moser D; Feuerecker M; Biere K; Han B; Hoerl M; Schelling G; Kaufmann I; Choukér A; Woehrle T
    Sci Rep; 2022 Sep; 12(1):15485. PubMed ID: 36109525
    [TBL] [Abstract][Full Text] [Related]  

  • 72. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased.
    Ihlow J; Michaelis E; Greuel S; Heynol V; Lehmann A; Radbruch H; Meinhardt J; Miller F; Herbst H; Corman VM; Westermann J; Bullinger L; Horst D; von Brünneck AC; Elezkurtaj S
    Int J Infect Dis; 2021 Feb; 103():628-635. PubMed ID: 33401036
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule.
    Cordeiro JFC; Fernandes TM; Toro DM; da Silva-Neto PV; Pimentel VE; Pérez MM; de Carvalho JCS; Fraga-Silva TFC; Oliveira CNS; Argolo JGM; Degiovani AM; Ostini FM; Puginna EF; da Silva JS; Santos IKFM; Bonato VLD; Cardoso CRB; Dias-Baruffi M; Faccioli LH; Donadi EA; Sorgi CA; Fernandes APM; On Behalf Of The Immunocovid Study Group
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients.
    Hoffmann AD; Weinberg SE; Swaminathan S; Chaudhuri S; Almubarak HF; Schipma MJ; Mao C; Wang X; El-Shennawy L; Dashzeveg NK; Wei J; Mehl PJ; Shihadah LJ; Wai CM; Ostiguin C; Jia Y; D'Amico P; Wang NR; Luo Y; Demonbreun AR; Ison MG; Liu H; Fang D
    Clin Immunol; 2023 Jul; 252():109634. PubMed ID: 37150240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
    Vasileiou S; Hill L; Kuvalekar M; Workineh AG; Watanabe A; Velazquez Y; Lulla S; Mooney K; Lapteva N; Grilley BJ; Heslop HE; Rooney CM; Brenner MK; Eagar TN; Carrum G; Grimes KA; Leen AM; Lulla P
    Haematologica; 2023 Jul; 108(7):1840-1850. PubMed ID: 36373249
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.
    Bidar F; Hamada S; Gossez M; Coudereau R; Lopez J; Cazalis MA; Tardiveau C; Brengel-Pesce K; Mommert M; Buisson M; Conti F; Rimmelé T; Lukaszewicz AC; Argaud L; Cour M; Monneret G; Venet F;
    Ann Intensive Care; 2022 Mar; 12(1):21. PubMed ID: 35246776
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19.
    Lucchese G; Vogelgesang A; Boesl F; Raafat D; Holtfreter S; Bröker BM; Stufano A; Fleischmann R; Prüss H; Franke C; Flöel A
    EBioMedicine; 2022 Sep; 83():104211. PubMed ID: 35963198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Observations of nemaline bodies in muscle biopsies of critically ill patients infected with SARS-CoV-2.
    Vandenabeele F; Stevens S; Snijders T; Stessel B; Dubois J; van Loon LJC; Lambrichts I; Agten A
    Microscopy (Oxf); 2023 Oct; 72(5):388-394. PubMed ID: 36574223
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Possible neglected transient (T) polyagglutination in critically ill patients with coronavirus disease-2019 (Covid-19).
    Gasim Dobie -; Hassan A Hamali -; Abdullah A Mobarki -; Muhammad Saboor -; Mohammad S Akhter -; Khaled Essawi Abdulrahim R Hakami -; Mohammed H Nahari -; Mohamed A Kolaiby -; Yahya H Matari -; Essa Atafi -; Ghalib Ghubiri -; Abdulrahman A Alhamzi -; Abdulrhman Alhamzi -; Amr J Halawani -; Abdullah Hamadi -; Denise E Jackson -
    Pak J Pharm Sci; 2023 Jul; 36(4):1211-1215. PubMed ID: 37599497
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial.
    Drewry AM; Mohr NM; Ablordeppey EA; Dalton CM; Doctor RJ; Fuller BM; Kollef MH; Hotchkiss RS
    Crit Care Med; 2022 Jun; 50(6):924-934. PubMed ID: 35120040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.